<!DOCTYPE html>
<html lang="en">
<head>
    <meta charset="UTF-8">
    <meta name="viewport" content="width=device-width, initial-scale=1.0">
    <title>Acute Rheumatic Fever (Dr. Mutai)</title>
    <link href="https://fonts.googleapis.com/css2?family=Inter:wght@400;500;600;700&display=swap" rel="stylesheet">
    <link rel="stylesheet" href="../styles/main.css">
    <!-- Include MathJax -->
    <script>
    MathJax = {
        tex: {
            inlineMath: [['$', '$'], ['\\(', '\\)']],
            displayMath: [['$$', '$$'], ['\\[', '\\]']],
            processEscapes: true,
            processEnvironments: true,
            tags: 'ams' // Use AMS numbering of equations
        },
        svg: { fontCache: 'global' },
        options: {
            skipHtmlTags: ['script', 'noscript', 'style', 'textarea', 'pre']
        }
    };
    </script>
    <script src="https://polyfill.io/v3/polyfill.min.js?features=es6"></script>
    <script id="MathJax-script" async src="https://cdn.jsdelivr.net/npm/mathjax@3/es5/tex-mml-chtml.js"></script>
</head>
<body>
    <div class="container">
        <article class="document-section" role="main">
            <!-- Top Navigation -->
            <nav class="document-nav" role="navigation" aria-label="Document Sections">
                <div class="nav-links">
                    <a href="../index.html" class="nav-button">
                        <span class="nav-icon"></span>
                        <span class="nav-text">Table of Contents</span>
                    </a>
                    <a href="cardiology-rheumatic-fever-1c.html" class="nav-button">
                        <span class="nav-icon">←</span>
                        <span class="nav-text">Previous Section</span>
                    </a>
                    <div class="document-progress">
                         <div class="progress-bar" aria-hidden="true">
                            <div class="progress-fill" style="width: 15.4%;"></div> <!-- Set percentage dynamically with static value for this chunk -->
                        </div>
                       <span class="progress-text">Lecture 8 of 52</span> <!-- Update text with static value for this chunk -->
                    </div>
                    <a href="cardiology-valvular-heart-disease-2a.html" class="nav-button">
                        <span class="nav-text">Next Section</span>
                        <span class="nav-icon">→</span>
                    </a>
                </div>
            </nav>

            <header class="section-header">
                <h1 class="section-title">ACUTE RHEUMATIC FEVER</h1>
                <p>MBchB IV</p>
                <p>DR. LOICE MUTAI PAEDIATRICIAN CARDIOLOGIST</p>
                <div class="title-underline"></div>
            </header>

            <main class="section-content">
                <!-- START: definition -->
                <section id="definition" class="content-section" aria-labelledby="section-heading-1">
                    <h2 id="section-heading-1" class="section-heading">
                         <span class="heading-icon"> </span>
                        <span class="heading-text">RHEUMATIC FEVER</span>
                    </h2>
                    <div class="content-card">
                        <p>Definition; RHF is an inflammatory disease which occurs as a delayed sequel to pharyngeal throat infection by B-hemolytic strep of Lancefield gp A after latency period of about 3-4 weeks.</p>
                        <ul>
                            <li>The pharyngitis is often purulent.</li>
                            <li>M Serotypes 3,5,18,19,24 have been frequently associated with RHF.</li>
                            <li>Not all strains in these serotypes are rheumatogenic</li>
                        </ul>
                        <p>Rheumatic process is an inflammatory reaction involving multiple organs- Joints, skin, brain and the heart.</p>
                        <ul>
                            <li>The usual manifestations in the acute form are; Migratory polyarthritis, fever and carditis.</li>
                            <li>Other manifestations are; Sydenham's Chorea, subcutaneous nodules and erythema marginatum.</li>
                        </ul>
                        <p>Joints, skin and brain involvement is normally self limited.</p>
                        <p>Cardiac involvement can lead to severe and life threatening acute inflammation or to a chronic disease that results in permanent cardiac scarring and dysfunction.</p>
                    </div>
                </section>
                <!-- END: definition -->

                <!-- START: epidemiology -->
                <section id="epidemiology" class="content-section" aria-labelledby="section-heading-2">
                    <h2 id="section-heading-2" class="section-heading">
                         <span class="heading-icon"> </span>
                        <span class="heading-text">EPIDEMIOLOGY</span>
                    </h2>
                    <div class="content-card">
                        <p>Untreated group A streptococcal pharyngitis precipitates an attack of RF in <u>2-3</u>% of individuals who've not had previous attack of RF. These individuals have genetic predisposition.</p>
                        <p>Some studies have emphasized relationship between occurrence of Rheumatic fever and severity of clinical manifestations of antecedent streptococcal pharyngitis.</p>
                        <p>However 1/3 of all cases of acute RF follow mild or almost asymptomatic pharyngitis. Some patients with Rheumatic heart disease have no history of pharyngitis.</p>
                        <p>Initial attacks of Rheumatic Fever are encountered between ages 6 and 15 years in developed world. In developing countries it seen at younger ages - up to 4 yrs.</p>
                        <p>Increased incidences of RF has been seen in young adults who're at risk of strep pharyngitis e.g. military recruits and parents of school age children.</p>
                        <ul>
                            <li>No sexual preference</li>
                            <li>Racial and ethnic differences in incidence of RF have been described;
                                <ul>
                                    <li>e.g. in New Zealand there's higher incidence among the Maori population.</li>
                                    <li>In the U.S. it is more common among African and Hispanic American than in caucasians.</li>
                                </ul>
                            </li>
                        </ul>
                        <p>Incidence of RF higher in developing countries. In developed world incidence was 0.5-3.1/100,000 at the turn of the century. In developing countries mortality from RHD is 10x higher than in the developed world.</p>
                        <p>Some of the factors which influence this are:</p>
                        <ul>
                            <li>Crowding in homes and schools</li>
                            <li>Availability of health care</li>
                            <li>Health seeking behavior.</li>
                        </ul>
                    </div>
                </section>
                <!-- END: epidemiology -->

                <!-- START: host-susceptibility -->
                <section id="host-susceptibility" class="content-section" aria-labelledby="section-heading-3">
                    <h2 id="section-heading-3" class="section-heading">
                         <span class="heading-icon"> </span>
                        <span class="heading-text">Host susceptibility</span>
                    </h2>
                    <div class="content-card">
                        <ul>
                            <li>Only 2-3% of individuals who've suffered strep pharyngitis develope RF. However in patients who've had RF previously, incidence is 50%</li>
                            <li>Genetic susceptibility is mediated by single recessive gene. Examination of human lymphocytes has revealed presence of a specific B cell alloantigen in 99 % of patients with RF and only 14 % in controls.</li>
                            <li>There is high incidence of class II human leucocyte (HLA) in patients with RF.</li>
                        </ul>
                    </div>
                </section>
                <!-- END: host-susceptibility -->

                <!-- START: pathogenesis -->
                <section id="pathogenesis" class="content-section" aria-labelledby="section-heading-4">
                    <h2 id="section-heading-4" class="section-heading">
                         <span class="heading-icon"> </span>
                        <span class="heading-text">PATHOGENESIS</span>
                    </h2>
                    <div class="content-card">
                        <h3 class="subsection-heading">Mechanism of Tissue injury</h3>
                        <ul>
                            <li>Thought to result from immune reaction</li>
                            <li>Kaplan et al showed that common antigenic determinants were shared between group A streptococci and myocardial tissue</li>
                        </ul>
                        <h3 class="subsection-heading">Antigenic mimicry</h3>
                        <ul>
                            <li>Antibodies produced against strep cross react with host tissue leading to tissue damage.</li>
                            <li>Strep M protein and myocardial sarcolemma have immunologic cross-reactivity.</li>
                            <li>Similar cross reactivity has been seen between a protoplast membrane antigen and sarcolemmal membrane of myocardium.</li>
                            <li>Other immunologic cross reactions:
                                <ul>
                                    <li>Streptococcal glycoprotein → valvular glycoprotein</li>
                                    <li>Strep protoplast → Neuronal tissue membrane of subthalamic and caudate nuclei.</li>
                                    <li>Hyaluronate of capsule → articular cartilage</li>
                                </ul>
                            </li>
                        </ul>
                    </div>
                </section>
                <!-- END: pathogenesis -->

                <!-- START: pathology -->
                <section id="pathology" class="content-section" aria-labelledby="section-heading-5">
                    <h2 id="section-heading-5" class="section-heading">
                         <span class="heading-icon"> </span>
                        <span class="heading-text">PATHOLOGY</span>
                    </h2>
                    <div class="content-card">
                        <p>Inflamatory reaction in RhF involves connective or collagen tissue. Most tissues of body maybe involved but clinically important manifestations primarily involve joints, heart and brain.</p>
                        <h3 class="subsection-heading">SKIN</h3>
                        <ul>
                            <li>Skin rash reflects presence of vasculitis mainly involving small vessels. Vessels show proliferation of endothelial cells.</li>
                            <li>Subcutaneous nodules rarely seen in acute Rh fever.</li>
                        </ul>
                        <h3 class="subsection-heading">Subcutaneous Nodules</h3>
                        <ul>
                            <li>Seen more in chronic valvular heart disease e.g. mitral stenosis.</li>
                            <li>Subcutaneous nodules consists of central fibrinoid recrosis surrounded by epithelial & mononuclear cells.</li>
                            <li>Lession similar to that described for Aschoff body (pathologic hallmark of Rheumatic Carditis)</li>
                        </ul>
                        <h3 class="subsection-heading">CARDIAC INVOLVEMENT</h3>
                        <p>In acute Rh fever, process often involves endocardium and myocardium. Pericardium may get involved in severe myocarditis.</p>
                        <h3 class="subsection-heading">PANCARDITIS</h3>
                        <ul>
                            <li>Histological findings not specific. Degree of histological change doesn't correlate with severity of clinical findings.</li>
                            <li>In early stages when cardiac dilation is a prominent feature, histological changes maybe minimal though cardiac function maybe so severely impaired as to be fatal.</li>
                            <li>As inflamatory rxn progresses, exudative and proliferative reaction becomes more apparent.</li>
                            <li>Oedematous changes occur in the tissues followed by a cellular infiltrate consisting of lymphocytes and plasma cells. Lymphocytes are predorminatly CD4 type.</li>
                            <li>Fibrinoid (eosinophilic granular substance) is seen scattered in the tissue, includes collagen fibres plus granular material derived from degenerating collagen in a mixture of fibrin, globulin and other substances.</li>
                            <li>Other tissues affected by disease process e.g. joint tissue may show fibrinoid necrosis.</li>
                            <li>Aschoff cell (Aschoff body) formation follows the above stage.</li>
                            <li>Lession consists of a perivascular infiltrate of large cells with polymorphous nuclei and basophilic cytoplasm arranged in a rossette around the centre of fibrinoid.</li>
                            <li>It is pathognomonic of Rheumatic carditis. Commonly found at IVS. LV wall and LA appendage.</li>
                            <li>Aschoff body not found in acute Rheumatic carditis but rather in patients with chronic disease.</li>
                        </ul>
                        <h3 class="subsection-heading">ENDOCARDITIS</h3>
                        <p>Affects valvular tissue and mitral endocardium. Mitral valve involvement is commonest. Aortic involvement is 2nd and much less frequent and pulmonary valve is rarely involved.</p>
                    </div>
                </section>
                <!-- END: pathology -->

                <!-- START: clinical-features -->
                <section id="clinical-features" class="content-section" aria-labelledby="section-heading-6">
                    <h2 id="section-heading-6" class="section-heading">
                         <span class="heading-icon"> </span>
                        <span class="heading-text">CLINICAL FEATURES</span>
                    </h2>
                    <div class="content-card">
                        <ul>
                            <li>Acute Rheumatic Carditis is manifested by appearance of heart murmurs.</li>
                            <li>In severe cases signs and symptoms of pericarditis and CCF will be eveident.</li>
                            <li>Death from heart failure may occur in the acute phase of the disease.</li>
                            <li>Permanent valvular damage may occur.</li>
                            <li>Carditis may range from a fulminating fatal course to a low grade subclinical inflammation.</li>
                        </ul>
                        <h3 class="subsection-heading">CARDITIS</h3>
                        <ul>
                            <li>Hence in patients whose RhF is manifested only as mild carditis, disease is often missed until later in life when they are found to have RHD. In such patients no definite history of RhF can be established.</li>
                            <li>Patients with acute carditis may manifest with tachycardia, cardiomegaly, hepatomegaly, changing heart murmurs</li>
                        </ul>
                        <h3 class="subsection-heading">ARTHRITIS</h3>
                        <ul>
                            <li>The classic attack of RhF appears as acute migratory polyarthritis and fever.</li>
                            <li>Large joints of upper and lower limbs are most frequently affected in a migratory manner.</li>
                            <li>Sometimes several joints are involved at the same time.</li>
                            <li>This is usually associated with high ESR.</li>
                        </ul>
                        <h3 class="subsection-heading">Subcutaneous Nodules</h3>
                        <ul>
                            <li>Small pea-sizes painless swellings over bony prominences.</li>
                            <li>Often not noticed.</li>
                            <li>Usually appear on extensor tendons of hands and feet, elbows,margins of patellae, scalp, scapulae, vertebrae etc.</li>
                        </ul>
                        <h3 class="subsection-heading">Erythema Marginatum</h3>
                        <ul>
                            <li>Erythematous rash with clear centres and round or serpiginous margins.</li>
                            <li>They occur on trunk and proximal part of extremeties and never on the face.</li>
                            <li>Rash is transient and migratory.</li>
                            <li>It is non-pruritic and not indurated.</li>
                        </ul>
                        <h3 class="subsection-heading">Chorea</h3>
                        <ul>
                            <li>Sydenham's chorea, St Vitus' dance.</li>
                            <li>Disorder of the CNS; Sudden aimless irregular movements often associated with muscle weakness and emotional instability.</li>
                            <li>Often a late manifestation which appears long after other features of acute RhF have subsided.</li>
                            <li>Onset gradual. Symptoms subside during sleep.</li>
                        </ul>
                    </div>
                </section>
                <!-- END: clinical-features -->

                <!-- START: diagnosis -->
                <section id="diagnosis" class="content-section" aria-labelledby="section-heading-7">
                    <h2 id="section-heading-7" class="section-heading">
                         <span class="heading-icon"> </span>
                        <span class="heading-text">GUIDELINES FOR DX RHF MODIFIED JONES CRITERIA (1992)</span>
                    </h2>
                    <div class="content-card">
                        <div class="table-container">
                            <table class="content-table">
                                <thead>
                                    <tr>
                                        <th>MAJOR MANIFESTATIONS</th>
                                        <th>MINOR</th>
                                    </tr>
                                </thead>
                                <tbody>
                                    <tr>
                                        <td>
                                            <ul>
                                                <li>Carditis</li>
                                                <li>Polyarthiritis</li>
                                                <li>Sydenham's chorea</li>
                                                <li>Erythema Marginatum</li>
                                                <li>Subcutaneous nodules</li>
                                            </ul>
                                        </td>
                                        <td>
                                            <p><strong>Clinical</strong></p>
                                            <ul>
                                                <li>Fever and arthralgia</li>
                                            </ul>
                                            <p><strong>Lab</strong></p>
                                            <ul>
                                                <li>↑ Acute phase reactants</li>
                                                <li>ESR, CRP</li>
                                                <li>Prolonged P-R interval</li>
                                            </ul>
                                        </td>
                                    </tr>
                                </tbody>
                            </table>
                        </div>
                        <h3 class="subsection-heading">SUPPORTING EVIDENCE OF ANTECEDENT Gp A STREP INFECTION</h3>
                        <ul>
                            <li>Increased or rising strep ab titre (s)</li>
                            <li>+ve throat culture or rapid strepcoccal ag test</li>
                        </ul>
                        <p>2 major or 1 major +2 minor manifestations indicates high probability of acute rheumatic fever. If supported by evidence of preceding group A throat infection.</p>
                    </div>
                </section>
                <!-- END: diagnosis -->

                <!-- START: treatment -->
                <section id="treatment" class="content-section" aria-labelledby="section-heading-8">
                    <h2 id="section-heading-8" class="section-heading">
                         <span class="heading-icon"> </span>
                        <span class="heading-text">Treatment</span>
                    </h2>
                    <div class="content-card">
                        <h3 class="subsection-heading">CARDITIS</h3>
                        <h4>Mild to moderate</h4>
                        <ul>
                            <li>Salicylates 90-100 mg/kg/day</li>
                            <li>Maintain serum levels 25-30 mg/dl</li>
                            <li>Treat for <u>4-6</u> weeks</li>
                            <li>With improvement treatment is withdrawn gradually over 2 weeks</li>
                        </ul>
                        <h4>Severe carditis</h4>
                        <ul>
                            <li>Prednisone 2 mg/kg/day. Given in acute period and gradually withdrawn over 2-3 wks.</li>
                            <li>One wk prior to withdrawal of steroids patient should be started on therapeutic dose of salicylates.</li>
                        </ul>
                        <h3 class="subsection-heading">Digitalis</h3>
                        <ul>
                            <li>Used in patients with severe carditis and heart failure. Digitalize (0-02-0.03 mg/kg) (TDD)</li>
                            <li>Then maintenance 1/4 TDD given in 2 doses daily</li>
                        </ul>
                        <h3 class="subsection-heading">Severe carditis</h3>
                        <ul>
                            <li>Additional cardiac drugs maybe considered if response is not adequate.</li>
                            <li>May use Lasix, aldactone.</li>
                            <li>Bed rest: Recommended for acute carditis with slow resumption of normal activity.</li>
                        </ul>
                        <h3 class="subsection-heading">ARTHRITIS</h3>
                        <ul>
                            <li>Salicylates (ASA) 50-70/kg/day for 2 months then gradually withdraw over 2-3 wks</li>
                            <li>Decline in ESR parallels clinical response</li>
                        </ul>
                        <h3 class="subsection-heading">SYDENHAM'S CHOREA</h3>
                        <h4>Mild:</h4>
                        <ul>
                            <li>Bed rest and avoidance of stress.</li>
                        </ul>
                        <h4>Severe:</h4>
                        <p>Anticonvulsants phenobarb or haloperidol.</p>
                        <ul>
                            <li>Phenobarbitone 3-8 mg/kg/day</li>
                            <li>Haloperidol: 0.5 mg/kg/day 8 hourly: may increase to 2 mg 8 hourly</li>
                            <li>Sodium valproate 15-20/kg/day</li>
                        </ul>
                    </div>
                </section>
                <!-- END: treatment -->

                <!-- START: prophylaxis -->
                <section id="prophylaxis" class="content-section" aria-labelledby="section-heading-9">
                    <h2 id="section-heading-9" class="section-heading">
                         <span class="heading-icon"> </span>
                        <span class="heading-text">PRIMARY PREVENTION</span>
                    </h2>
                    <div class="content-card">
                        <p>Eradication of steptococci</p>
                        <ul>
                            <li>Benzathine pen 600,000-1.2 m.u.</li>
                            <li>Pen V 250 mg TDS x10/7</li>
                            <li>Erthromycin 20-40 g/kg/dx 10/</li>
                        </ul>
                        <p>Others:</p>
                        <ul>
                            <li>Cefpodoxime 10 mg/kg/24hr x 5/7-od</li>
                            <li>Azitromycin 12 mg/Kg/day x12/7-od</li>
                        </ul>
                    </div>
                </section>
                <!-- END: prophylaxis -->

                <!-- START: secondary-prophylaxis -->
                <section id="secondary-prophylaxis" class="content-section" aria-labelledby="section-heading-10">
                    <h2 id="section-heading-10" class="section-heading">
                         <span class="heading-icon"> </span>
                        <span class="heading-text">PROPHYLAXIS</span>
                    </h2>
                    <div class="content-card">
                        <h3 class="subsection-heading">Secondary prevention</h3>
                        <ul>
                            <li>3 to 4 weekly Benzathine pen G 600,000 IU for <27 kg. 1.2 m.u. >27 kg</li>
                            <li>Others: Pen V, sulfadiazine, erythromycin</li>
                        </ul>
                        <h3 class="subsection-heading">Health education of parents / caretakers and child.</h3>
                        <p>END Thankyou</p>
                    </div>
                </section>
                <!-- END: secondary-prophylaxis -->
            </main>

            <!-- Bottom Navigation -->
             <nav class="document-nav" role="navigation" aria-label="Document Sections">
                <div class="nav-links">
                    <a href="../index.html" class="nav-button">
                        <span class="nav-icon"></span>
                        <span class="nav-text">Table of Contents</span>
                    </a>
                    <a href="cardiology-rheumatic-fever-1c.html" class="nav-button">
                        <span class="nav-icon">←</span>
                        <span class="nav-text">Previous Section</span>
                    </a>
                    <div class="document-progress">
                         <div class="progress-bar" aria-hidden="true">
                            <div class="progress-fill" style="width: 15.4%;"></div>
                        </div>
                       <span class="progress-text">Lecture 8 of 52</span>
                    </div>
                    <a href="cardiology-valvular-heart-disease-2a.html" class="nav-button">
                        <span class="nav-text">Next Section</span>
                        <span class="nav-icon">→</span>
                    </a>
                </div>
            </nav>

        </article>
    </div>
    <script src="../js/navigation.js"></script>
</body>
</html>